Completed
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
NCT03435081
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Johnson Dermatology Fort Smith, Arkansas, United States
- Wallace Medical Group, Inc. Beverly Hills, California, United States
- California Dermatology and Clinical Research Institute Encinitas, California, United States